Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07640061
PHASE1
Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release
Sponsor: Wright State University
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine the amount of substances contained in skin known as microvesicle particles (MVP). The hypothesis to be tested in this study is that treatment with a single dose of 75mg of amitriptyline will block the MVP released from the skin from a very small localized burn injury.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2027-06
Completion Date
2033-06
Last Updated
2026-06-10
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Amitriptyline
75mg amitriptyline
DRUG
Placebo
Placebo
Locations (1)
Wright State University - Pharmacology Translational Unit
Fairborn, Ohio, United States